These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8118494)

  • 1. Use of a mechanical pressure device for hemostasis following cardiac catheterization.
    Simon AW
    Am J Crit Care; 1994 Jan; 3(1):62-4. PubMed ID: 8118494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manual versus mechanical compression for femoral artery hemostasis after cardiac catheterization.
    Simon A; Bumgarner B; Clark K; Israel S
    Am J Crit Care; 1998 Jul; 7(4):308-13. PubMed ID: 9656045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achieving femoral artery hemostasis after cardiac catheterization: a comparison of methods.
    Schickel SI; Adkisson P; Miracle V; Cronin SN
    Am J Crit Care; 1999 Nov; 8(6):406-9. PubMed ID: 10553181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
    Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinksi EJ; Roubin GS
    J Invasive Cardiol; 1999 Sep; 11 Suppl B():6B-13B. PubMed ID: 10745611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular hemostasis bandage compared to standard manual compression after cardiac catheterization in children.
    Waragai T; Morgan G; Ralston T; Chaturvedi R; Lee KJ; Benson L
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):262-6. PubMed ID: 21538780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients.
    Eggebrecht H; Haude M; Woertgen U; Schmermund A; von Birgelen C; Naber C; Baumgart D; Kaiser C; Oldenburg O; Bartel T; Kroeger K; Erbel R
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):486-95. PubMed ID: 12455083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of a hemostatic device with percutaneous collagen application (VasoSeal) compared to a mechanical compression system (Compressar) after transfemoral catheterization of patients suffering from arterial occlusive disease].
    Neudecker A; Manke C; Lenhart M; Zorger N; Paetzel C; Feuerbach S; Link J
    Rofo; 2003 May; 175(5):676-81. PubMed ID: 12743862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression.
    Deuling JH; Vermeulen RP; Anthonio RA; van den Heuvel AF; Jaarsma T; Jessurun G; de Smet BJ; Tan ES; Zijlstra F
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):518-23. PubMed ID: 18307223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and effectiveness of a novel vascular hemostatic device (Chula-clamp) after coronary angiography or percutaneous coronary intervention.
    Plainetr V; Itsathitpaisam W; Chaipromprasit J; Srimahachota S; Sukseree Y; Songmuang SB
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S180-8. PubMed ID: 17718286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with the Cardiva Boomerang Catalyst system in pediatric cardiac catheterization.
    Seltzer S; Alejos JC; Levi DS
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):476-81. PubMed ID: 19360859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The experience with the Epiclose-T vascular access closure device: a human study.
    Kurşaklioğlu H; Iyisoy A; Barçin C; Celik T; Nitzan R; Köse S; Amasyali B; Işik E
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):38-42. PubMed ID: 18258532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of mechanical compression devices in attaining hemostasis after femoral sheath removal.
    Jones T; McCutcheon H
    Am J Crit Care; 2002 Mar; 11(2):155-62. PubMed ID: 11888128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience with the Cardiva Boomerang vascular closure device in diagnostic catheterization.
    Doyle BJ; Godfrey MJ; Lennon RJ; Ryan JL; Bresnahan JF; Rihal CS; Ting HH
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):203-8. PubMed ID: 17195965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous suture-mediated closure of femoral access sites deployed through the procedure sheath: initial clinical experience with a novel vascular closure device.
    Eggebrecht H; Naber C; Woertgen U; Ringe S; Konorza TF; Schmermund A; von Birgelen C; Haude M; Kroeger K; Erbel R; Baumgart D
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):313-21. PubMed ID: 12594694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of local adverse events following cardiac catheterization by hemostasis device use - phase II.
    Tavris DR; Dey S; Albrecht-Gallauresi B; Brindis RG; Shaw R; Weintraub W; Mitchel K
    J Invasive Cardiol; 2005 Dec; 17(12):644-50. PubMed ID: 16327045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of hemostatic puncture closing device for hemostasis and early ambulation after coronary angiography and angioplasty: results of a multicenter trial].
    Magosaki N; Hosoda S; Kawagishi N; Yamaguchi T; Sakatani H; Haze K; Itagane H; Otsuka M; Nobuyoshi M; Yokoi H
    J Cardiol; 1999 Sep; 34(3):131-8. PubMed ID: 10500973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radial compression guided by mean artery pressure versus standard compression with a pneumatic device (RACOMAP).
    Cubero JM; Lombardo J; Pedrosa C; Diaz-Bejarano D; Sanchez B; Fernandez V; Gomez C; Vazquez R; Molano FJ; Pastor LF
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):467-72. PubMed ID: 19229978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful reduction of surgeries secondary to arterial access site complications: a retrospective review at a single center with an extravascular closure device.
    Noor S; Meyers S; Curl R
    Vasc Endovascular Surg; 2010 Jul; 44(5):345-9. PubMed ID: 20484072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of local adverse events following cardiac catheterization by hemostasis device use and gender.
    Tavris DR; Gallauresi BA; Lin B; Rich SE; Shaw RE; Weintraub WS; Brindis RG; Hewitt K
    J Invasive Cardiol; 2004 Sep; 16(9):459-64. PubMed ID: 15353824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention using thrombin hemostatic patch-facilitated manual compression.
    Applegate RJ; Sacrinty MT; Kutcher MA; Baki TT; Gandhi SK; Santos RM; Kahl FR; Little WC
    J Invasive Cardiol; 2007 Apr; 19(4):164-70. PubMed ID: 17404401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.